BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27528226)

  • 1. Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery.
    Pei Q; Zhu H; Tan F; Yu N; Zhou Z; Zhou Y; Song X; Li Y; Tao Y; Zhang S; Li L; Li Q; Pei H
    Oncotarget; 2016 Aug; 7(35):57268-57276. PubMed ID: 27528226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular emboli relates to immunosuppressive tumor microenvironment and predicts prognosis in stage III colorectal cancer.
    Song X; Xie D; Tan F; Zhou Y; Li Y; Zhou Z; Pei Q; Pei H
    Aging (Albany NY); 2021 Aug; 13(16):20609-20628. PubMed ID: 34438367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer].
    Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
    Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
    Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
    Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
    Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma.
    Park YY; An CH; Oh ST; Chang ED; Lee J
    Medicine (Baltimore); 2019 Aug; 98(32):e16709. PubMed ID: 31393377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133 expression is correlated with poor prognosis in colorectal cancer.
    Kashihara H; Shimada M; Kurita N; Iwata T; Sato H; Kozo Yoshikawa ; Higashijima J; Chikakiyo M; Nishi M; Matsumoto N
    Hepatogastroenterology; 2014 Sep; 61(134):1563-7. PubMed ID: 25436343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.
    Huh JW; Kim HR; Kim YJ
    J Am Coll Surg; 2013 Jun; 216(6):1063-9. PubMed ID: 23571142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.
    Li Q; Liang L; Jia H; Li X; Xu Y; Zhu J; Cai S
    Oncotarget; 2016 Nov; 7(44):72290-72299. PubMed ID: 27474167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery.
    Nakamura K; Iinuma H; Aoyagi Y; Shibuya H; Watanabe T
    Oncology; 2010; 78(5-6):309-15. PubMed ID: 20616575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival nomograms for stage III colorectal cancer.
    Li C; Pei Q; Zhu H; Tan F; Zhou Z; Zhou Y; Li Y; Pei H
    Medicine (Baltimore); 2018 Dec; 97(49):e13239. PubMed ID: 30544384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients.
    Artells R; Moreno I; Díaz T; Martínez F; Gel B; Navarro A; Ibeas R; Moreno J; Monzó M
    Eur J Cancer; 2010 Feb; 46(3):642-9. PubMed ID: 20005089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
    Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
    Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of NLRC3 with prognosis and tumor immunity in patients with stage III colorectal cancer].
    Wang D; Pei Q; Tan F; Zhou Y; Wang K; Pei H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):535-543. PubMed ID: 31303617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of periostin in the liver metastasis of colorectal cancer.
    Wu G; Wang X; Zhang X
    Cancer Biother Radiopharm; 2013 May; 28(4):298-302. PubMed ID: 23347152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study.
    Tougeron D; Sickersen G; Mouillet G; Zaanan A; Trouilloud I; Coriat R; Aparicio T; Des Guetz G; Lecaille C; Artru P; Cauchin E; Sefrioui D; Boussaha T; Ferru A; Matysiak-Budnik T; Silvain C; Karayan-Tapon L; Pagès JC; Vernerey D; Bonnetain F; Michel P; Taïeb J; Lecomte T;
    Eur J Cancer; 2015 May; 51(8):925-34. PubMed ID: 25864037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of family history on survival in patients with colon and rectal cancer.
    Lee SD; Kim BC; Han KS; Hong CW; Sohn DK; Park JW; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Mar; 15(3):108-15. PubMed ID: 24304621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metastatic lymph node ratio and outcome of surgical patients with stage III colorectal cancer].
    Liang J; Wei Y; Zhao C; Hong C
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1663-6. PubMed ID: 23174600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.